Combination Therapy of Intravenous Maxacalcitol and Percutaneous Ethanol Injection Therapy Lowers Serum Parathyroid Hormone Level and Calcium × Phosphorus Product in Secondary Hyperparathyroidism
暂无分享，去创建一个
T. Fujita | T. Fujita | M. Matsushita | H. Helin | H. Trimarchi | M. Inaba | J. Mustonen | A. Pasternack | H. Saha | M. Endo | A. Satomura | Y. Nishizawa | Y. Imanishi | E. Ishimura | C. Park | M. Koukoulaki | T. Miki | Koichi Matsumoto | L. Vercaigne | Y. Fuke | M. Forrester | I. Ohsawa | B. Cho | Sung-Do Kim | P. Young | J. Schropp | H. Pereyra | E. Freixas | H. Ohi | S. Jono | C. Raymond | J. Myllymäki | Eun-Hui Wang | B. Kalender | K. Bernstein | A. C. Ozdemir | Kaname Hirowatari | T. Tsuchida | D. M. Collins | Dan E. Skwarchuk | S. Sudo | Yeong-Jin Choi | N. Matsumoto | Y. B. Goh | In Sung Moon | Kweon-Heang Lee | Sung Hak Kang | Chang Suk Kang | D. Jayne | G. Koroglu